CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 1.96 HKD -1.51% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

CStone Pharmaceuticals
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CStone Pharmaceuticals
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
CStone Pharmaceuticals
HKEX:2616
Short-Term Investments
ÂĄ330.2m
CAGR 3-Years
218%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Short-Term Investments
ÂĄ7.5B
CAGR 3-Years
-32%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Short-Term Investments
ÂĄ2.5B
CAGR 3-Years
188%
CAGR 5-Years
506%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Short-Term Investments
ÂĄ1.5B
CAGR 3-Years
87%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Short-Term Investments
ÂĄ1.5B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CStone Pharmaceuticals
Glance View

Market Cap
2.5B HKD
Industry
Biotechnology

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 264 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

Intrinsic Value
3.12 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is CStone Pharmaceuticals's Short-Term Investments?
Short-Term Investments
330.2m CNY

Based on the financial report for Jun 30, 2024, CStone Pharmaceuticals's Short-Term Investments amounts to 330.2m CNY.

What is CStone Pharmaceuticals's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
-28%

Over the last year, the Short-Term Investments growth was -41%. The average annual Short-Term Investments growth rates for CStone Pharmaceuticals have been 218% over the past three years , -28% over the past five years .

Back to Top